Search
for
Sort by
Research 631–660 of 1000+
- Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: An intrasubject pilot study
- The lanceolate hair rat phenotype results from a missense mutation in a calcium coordinating site of the desmoglein 4 gene
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia
- Alopecia areata update
- Alopecia areata: diagnosis and management
- What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
- Central scalp alopecia photographic scale in AfricanAmerican women
- Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia
- Retrospective Review of Folliculitis Decalvans in 23 Patients with Course and Treatment Analysis of Long-standing Cases
- Clinical utility and validity of minoxidil response testing in androgenetic alopecia
- Alefacept for Severe Alopecia Areata
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Diagnosis and Management of Primary Cicatricial Alopecia: Part I
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: A clinical and immunopathologic evaluation
- The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata
- Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management
- Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
- Objective outcome measures: Collecting meaningful data on alopecia areata
- Novel Treatment Using Low-Dose Naltrexone for Lichen Planopilaris.
- Pseudopelade of Brocq
- Use of Finasteride in the Treatment of Men With Androgenetic Alopecia (Male Pattern Hair Loss)
- Medical therapy for frontal fibrosing alopecia: A review and clinical approach
- p53‐dependent transcriptional regulation of EDA2R and its involvement in chemotherapy‐induced hair loss
- 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia
- Prognosis, treatment, and disease outcomes in frontal fibrosing alopecia: A retrospective review of 92 cases
- A review of scalp camouflaging agents and prostheses for individuals with hair loss
- Promising therapies for treating and/or preventing androgenic alopecia.
- Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata